AFOS Short Volume
ARS Focused Opportunity Strategy ETF (AFOS) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $279.4M, listed on NASDAQ, carrying a beta of 1.35 to the broader market. Actively managed, high-conviction ETF investing across market caps (small to large), focused on companies positioned to benefit from secular trends and demonstrating value, with the aim of growing purchasing power over time. public since 2025-06-26.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-01
- Short Volume
- 1.4K
- Total Volume
- 10.2K
- Short %
- 14.05%
- 30-Day Avg Short %
- 54.59%
Showing 30 days of FINRA short volume data for ARS Focused Opportunity Strategy ETF.
Learn how short volume is reported and how to read the data →
Frequently asked AFOS short volume questions
- What is the daily AFOS short volume?
- As of Jun 1, 2026, ARS Focused Opportunity Strategy ETF (AFOS) short volume is 1.4K shares against 10.2K total reported volume, or 14.05% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is AFOS short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does AFOS short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.